Actively Recruiting
Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia
Led by The University of Texas Health Science Center, Houston · Updated on 2025-09-10
688
Participants Needed
1
Research Sites
131 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the effectiveness of small phlebotomy tubes to reduce RBC transfusions in medical intensive care unit (ICU) and Intermediate care unit (IMU) patients with low hemoglobin compared with standard size tubes, to compare the intervention and the control groups in regards to: ICU length of stay (LOS), ICU mortality, hospital LOS, and hospital mortality and to assess the acceptability of small phlebotomy tubes in adult ICU and IMU patients.
CONDITIONS
Official Title
Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Admission to the medical ICU or IMU
- Hemoglobin less than 10 g/dL
You will not qualify if you...
- Clinical bleeding requiring intervention such as increased hemoglobin monitoring, transfusion, procedure, or consultation
- Hemolytic disorders such as sickle cell disease, hereditary spherocytosis, or autoimmune hemolytic anemia
- Bone marrow disorders including aplastic anemia, leukemia, marrow infiltration disorder, or chemotherapy within the last 8 weeks
- Jehovah's Witnesses
- Patients receiving comfort care measures only
- Refractory shock defined as mean arterial blood pressure below 65 mmHg despite maximal doses of 3 vasopressors
- Severe acidosis with pH below 7 in more than one arterial blood gas in the past 24 hours (unless diabetic ketoacidosis)
- Surgical admission diagnosis
- Pregnancy
- Current prisoner
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
J
Javier Barreda Garcia, MD
CONTACT
I
Ibilola A Sanusi, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here